Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

A new one-step test can quickly identify skin cancer during surgery.

Erlotinib can cause hair loss and texture changes.

Cetirizine lotion can effectively treat female pattern hair loss.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Keratinocytes can reduce the survival of certain melanoma cells, suggesting new therapy paths.

Cepharanthine can block enterovirus entry and protect against infection.

Chemotherapy with docetaxel and cisplatin can cause severe low potassium, requiring careful monitoring and treatment.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

PRIDE syndrome helps identify skin side effects from EGFR inhibitors like erlotinib.

Cimetidine does not significantly reduce hair growth in hirsutism.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

Cyclophosphamide is preferred for severe cases in pediatric rheumatology and nephrology despite its side effects.

Effective treatment for UFT overdose includes antibiotics and G-CSF, with bone marrow biopsy and transfusion as backup options.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

A new microneedle patch significantly improves melanoma treatment by using a special material to activate cancer-fighting drugs and disrupt cancer cells.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.

A special gel with medicine helps prevent melanoma from coming back after surgery.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.

Erlotinib can cause acne-like skin issues, needing early treatment and possible dosage adjustments.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

A chemical called 5-Bromo-2′-deoxyuridine caused rapid hair loss in mice by killing certain skin cells through a specific cell death pathway.